understanding non-response and loss of response in ibd: which is it and when do we change classes?
Published 7 years ago • 10K plays • Length 26:25Download video MP4
Download video MP3
Similar videos
-
14:13
what do we do when the patient loses their response to an anti-tnf?
-
26:49
update on the therapeutic drug monitoring in ibd: for use in situations other than loss of response?
-
27:12
evaluating and treating pain in ibd
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
20:09
recent and emerging crohn's disease therapies
-
29:46
case discussion: when and how to modify ibd therapies
-
26:14
mechanisms of disease: unraveling the small molecule pipeline for ibd
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease
-
28:12
current and evolving therapeutic landscape of ibd
-
20:48
defining an ibd patient's disease severity and prognosis
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
29:32
keynote speaker: what will it take to develop the cures for ulcerative colitis and crohn's disease
-
20:05
ibd pathogenesis: personalizing targets
-
21:30
ibd: beyond combination therapy
-
21:36
crohn's disease: recent and emerging therapies
-
33:25
do we know the cause(s) of ibd: update on the microbiome with the risk study as a model
-
27:21
inflammatory bowel disease and pregnancy
-
20:38
creating the ibd health maintenance check list: keeping up with quality
-
21:59
the treatment of moderate to severe ibd with anti-tnf biologics and immunomodulators